Satoru Takada

Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group

Fumihiko Hayakawa, Toru Sakura, Toshiaki Yujiri et al. · Blood Cancer Journal · 2014 · 105 citations · Full text

Medicine, Oncology, Pediatrics +14

Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study

Naoto Takahashi, Tetsuzo Tauchi, Kunio Kitamura et al. · International Journal of Hematology · 2017 · 94 citations

Medicine, Hematology, Oncology +3

Philadelphia chromosome‐positive mixed phenotype acute leukemia in the imatinib era

Hiroaki Shimizu, Akihiko Yokohama, Nahoko Hatsumi et al. · European Journal Of Haematology · 2014 · 59 citations · Full text

Medicine, Hematology, Oncology +17

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of <i>CDX2</i> and <i>IDH1/2</i> mutations

Takahiko Yasuda, Masashi Sanada, Masahito Kawazu et al. · Blood · 2021 · 53 citations · Full text

Medicine, Hematology, Oncology +10

Clinical significance of granulocytic sarcoma in adult patients with acute myeloid leukemia

Hiroaki Shimizu, Takayuki Saitoh, Nahoko Hatsumi et al. · Cancer Science · 2012 · 48 citations · Full text

Medicine, Hematology, Oncology +17